Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Companies / V•• B•• C•••

V•• B•• C•••

Series ASan Diego, CAPharmaceuticals
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
2 rounds
  1. Mar 17, 2026
    Series A · amount undisclosed
    C••••••••• G••••• (lead)
    Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) · “V•• B•• C•••oration Announces Series A Financing to Advance VB-001 and Adds W•••••• S•••• to Board of Directors”
  2. Nov 5, 2025
    Form D equity offering · $31.9M (form d sold) · 1 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “V•• B•• C••• filed Form D/A: $31,888,146 sold of $31,888,146, Pharmaceuticals”
Investors on record
1 edges
People
2 officers, 4 directors
Timeline
3
  1. Apr 24, 2026
    V•• B•• C••• filed Form D/A: $31,888,146 sold of $31,888,146, Pharmaceuticals
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Mar 17, 2026
    V•• B•• C•••oration announced Series A, led by C••••••••• G•••••
    Round announced Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS)
  3. Nov 18, 2025
    V•• B•• C••• filed Form D: $28,888,146 sold of $28,888,146, Pharmaceuticals
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
29 observations
Every observation on this company